Substituted 4-amino-1H-pyrazolo[3,4-d]pyrimidines as multi-targeted inhibitors of insulin-like growth factor-1 receptor (IGF1R) and members of ErbB-family receptor kinases

被引：23

作者：

Wang, Gary T. ^{[1
]}

Mantei, Robert A. ^{[1
]}

Hubbard, Robert D. ^{[1
]}

Wilsbacher, Julie L. ^{[1
]}

Zhang, Qian ^{[1
]}

Tucker, Lora ^{[1
]}

Hu, Xiaoming ^{[1
]}

Kovar, Peter ^{[1
]}

Johnson, Eric F. ^{[1
]}

Osterling, Donald J. ^{[1
]}

Bouska, Jennifer ^{[1
]}

Wang, Jieyi ^{[1
]}

Davidsen, Steven K. ^{[1
]}

Bell, Randy L. ^{[1
]}

Sheppard, George S. ^{[1
]}

机构：

[1] Abbott Labs, Global Pharmaceut Res & Dev, Abbott Pk, IL 60064 USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2010年 / 20卷 / 20期

关键词：

Multi-targeted kinase inhibitors; IGF1R; EGFR; ErbB2; ACQUIRED-RESISTANCE; ANTITUMOR-ACTIVITY; CANCER-CELLS; POTENT; DISCOVERY; LAPATINIB; ANTIBODY; BREAST;

D O I：

10.1016/j.bmcl.2010.08.052

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

This Letter describes the lead discovery, optimization, and biological characterization of a series of substituted 4-amino-1H-pyrazolo[3,4-d]pyrimidines as potent inhibitors of IGF1R, EGFR, and ErbB2. The leading compound 11 showed an IGF1R IC50 of 12 nM, an EGFR (L858R) IC50 of 31 nM, and an ErbB2 IC50 of 11 nM, potent activity in cellular functional and anti-proliferation assays, as well as activity in an in vivo pharmacodynamic assay. (C) 2010 Elsevier Ltd. All rights reserved.

引用

页码：6067 / 6071

页数：5

共 50 条

[41] Anti-tumor activities of a dual kinase inhibitor of the insulin-like growth factor receptor (IGF1R) and the epidermal growth factor receptor (EGFR/ERbB) families
Wang, Jieyi
Meulbroek, Jon
Zhang, Qian
Tucker, Lora
Wilsbacher, Julie
Hu, Xiaoming
Pappano, William
Hubbard, Robert
Osterling, Donald
Bouska, Jennifer
Johnson, Eric
Donawho, Cherrie
Buchanan, Greg
Sheppard, George
Davidsen, Steve
Bell, Randy
CANCER RESEARCH, 2009, 69
[42] Targeting the insulin-like growth factor-1 receptor (IGF-1R) in the treatment of metastazising uveal melanoma
Ericsson, CB
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2004, 45 : U514 - U514
[43] Antisense Oligonucleotide Targeting of Insulin-Like Growth Factor-1 Receptor (IGF-1R) in Prostate Cancer
Furukawa, Junya
Wraight, Christopher J.
Freier, Susan M.
Peralta, Eigan
Atley, Lynne M.
Monia, Brett P.
Gleave, Martin E.
Cox, Michael E.
PROSTATE, 2010, 70 (02): : 206 - 218
[44] Identification of a gonad-expression differential gene insulin-like growth factor-1 receptor (Igf1r) in the swamp eel (Monopterus albus)
Mei, Jie
Yan, Wei
Fang, Jie
Yuan, Gailing
Chen, Nan
He, Yan
FISH PHYSIOLOGY AND BIOCHEMISTRY, 2014, 40 (04) : 1181 - 1190
[45] Association between insulin-like growth factor-1 receptor (IGF1R) negativity and poor prognosis in a cohort of women with primary breast cancer
Kristina E Aaltonen
Ann H Rosendahl
Hans Olsson
Per Malmström
Linda Hartman
Mårten Fernö
BMC Cancer, 14
[46] Compensatory Insulin Receptor (IR) Activation on Inhibition of Insulin-Like Growth Factor-1 Receptor (IGF-1R): Rationale for Cotargeting IGF-1R and IR in Cancer
Buck, Elizabeth
Gokhale, Prafulla C.
Koujak, Susan
Brown, Eric
Eyzaguirre, Alexandra
Tao, Nianjun
Rosenfeld-Franklin, Maryland
Lerner, Lorena
Chiu, M. Isabel
Wild, Robert
Epstein, David
Pachter, Jonathan A.
Miglarese, Mark R.
MOLECULAR CANCER THERAPEUTICS, 2010, 9 (10) : 2652 - 2664
[47] Identification of a gonad-expression differential gene insulin-like growth factor-1 receptor (Igf1r) in the swamp eel (Monopterus albus)
Jie Mei
Wei Yan
Jie Fang
Gailing Yuan
Nan Chen
Yan He
Fish Physiology and Biochemistry, 2014, 40 : 1181 - 1190
[48] Association between insulin-like growth factor-1 receptor (IGF1R) negativity and poor prognosis in a cohort of women with primary breast cancer
Aaltonen, Kristina E.
Rosendahl, Ann H.
Olsson, Hans
Malmstrom, Per
Hartman, Linda
Ferno, Marten
BMC CANCER, 2014, 14
[49] Insulin-like growth factor-1 receptor crosstalk with integrins, cadherins, and the tumor microenvironment: sticking points in understanding IGF1R function in cancer
Galifi, Christopher A.
Wood, Teresa L.
ENDOCRINE-RELATED CANCER, 2023, 30 (10)
[50] Preclinical evaluation of Insulin-like growth factor receptor 1 (IGF1R) and Insulin Receptor (IR) as a therapeutic targets in triple negative breast cancer
Roche, Sandra
Gaule, Patricia
Winrow, Deirdre
Mukherjee, Nupur
O'Neill, Fiona
Conlon, Neil T. T.
Meiller, Justine
Collins, Denis M. M.
Canonici, Alexandra
Fawsi, Mohammed Ibrahim
Estepa-Fernandez, Alejandra
Madden, Stephen F. F.
Crown, John
O'Donovan, Norma
Eustace, Alex J. J.
PLOS ONE, 2023, 18 (03):

← 1 2 3 4 5 →